Growth Metrics

Acadia Pharmaceuticals (ACAD) EPS (Basic) (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Acadia Pharmaceuticals 3.69 Bn 2.84 Bn 243.27 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -98.77%
Dec 31, 2025 276.74%
Sep 30, 2025 168.75%
Jun 30, 2025 45.45%
Mar 31, 2025 -87.36%
Dec 31, 2024 335.00%
Sep 30, 2024 0.00%
Jun 30, 2024 100.00%
Mar 31, 2024 -64.29%
Dec 31, 2023 170.00%
Sep 30, 2023 -4,100.00%
Jun 30, 2023 103.70%
Mar 31, 2023 -3.85%
Dec 31, 2022 -52.94%
Sep 30, 2022 19.05%
Jun 30, 2022 70.00%
Mar 31, 2022 -159.26%
Dec 31, 2021 -200.00%
Sep 30, 2021 66.67%
Jun 30, 2021 35.71%
Mar 31, 2021 0.00%
Dec 31, 2020 -740.00%
Sep 30, 2020 81.48%
Jun 30, 2020 52.63%
Mar 31, 2020 -67.65%
Dec 31, 2019 -17.24%
Sep 30, 2019 23.68%
Jun 30, 2019 35.59%
Mar 31, 2019 -18.00%
Dec 31, 2018 0.00%
Sep 30, 2018 1.96%
Jun 30, 2018 -15.91%
Mar 31, 2018 20.00%
Dec 31, 2017 -3.77%
Sep 30, 2017 3.64%
Jun 30, 2017 23.61%
Mar 31, 2017 -10.77%
Dec 31, 2016 -6.56%
Sep 30, 2016 3.17%
Jun 30, 2016 -40.00%
Mar 31, 2016 0.00%
Dec 31, 2015 -15.38%
Sep 30, 2015 0.00%
Jun 30, 2015 2.50%
Mar 31, 2015 -42.86%
Dec 31, 2014 -12.00%
Sep 30, 2014 -13.64%
Jun 30, 2014 -15.79%
Mar 31, 2014 -46.15%
Dec 31, 2013 -8.33%
Sep 30, 2013 -9.09%
Jun 30, 2013 -37.50%
Mar 31, 2013 27.27%
Dec 31, 2012 -175.00%
Sep 30, 2012 60.00%
Jun 30, 2012 16.67%
Mar 31, 2012 -20.00%
Dec 31, 2011 0.00%
Sep 30, 2011 16.67%
Jun 30, 2011 0.00%
Mar 31, 2011 -115.79%
Dec 31, 2010 790.91%